Jean-Michel Vannetzel

Papers

Total Citations

H-Index

About

Jean-Michel Vannetzel is a leading figure in radiation oncology, with a specialized focus on the clinical implementation and optimization of stereotactic body radiation therapy (SBRT). His work centers on enhancing the precision and safety of robotic radiosurgery, particularly through the use of fiducial markers for real-time tumor tracking. His most cited study, a 2019 investigation on the safety and efficacy of fiducial marker implantation for robotic SBRT with fiducial tracking (41 citations), established critical benchmarks for feasibility and toxicity in treating extracranial tumors. This research has been instrumental in refining protocols for CyberKnife® systems, directly impacting how clinicians manage organ motion during treatment. Beyond this landmark paper, Vannetzel’s contributions have shaped best practices in interventional oncology, bridging the gap between procedural innovation and patient outcomes. His work is widely referenced by peers seeking to improve the accuracy of dose delivery while minimizing collateral damage to healthy tissue. With a career dedicated to advancing non-invasive cancer therapies, Vannetzel remains a key voice in the evolution of image-guided radiation, influencing both technical standards and clinical decision-making in modern radiotherapy.